A new variant of COVID-19 called XEC is spreading rapidly in Europe and other parts of the world, just after a summer with an ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...

The new and contagious XEC COVID-19 variant is spreading rapidly in several countries. Will it cause a surge in the U.S.?

Currently available COVID vaccines target slightly different subvariants. The updated mRNA shots aimed at KP.2 from ...

Understanding this “checkerboard” pattern may help determine when best to get a COVID-19 vaccine booster, researchers said.

The monovalent XBB.1.5 COVID-19 vaccine is effective against XBB and JN lineage hospitalization; however, protection against the latter may be attenuated.

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Building upon the success of large-scale genome sequencing during the COVID-19 pandemic, particularly with SARS-CoV-2 variant tracking, this Research Topic aims to explore solutions enabling the ...

Modified nucleotides like m5C in saRNA enhance vaccine efficacy, stability, and reduce inflammation, offering a promising ...

The proportion of US patients reporting a lot of trust for physicians and hospitals decreased by about 30% over the COVID-19 pandemic.